{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:01:14Z","timestamp":1792098074672,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T00:00:00Z","timestamp":1255046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00296-009-1178-y","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T08:22:40Z","timestamp":1254990160000},"page":"243-245","source":"Crossref","is-referenced-by-count":59,"title":["Successful switching to adalimumab in an infliximab-allergic patient with severe Beh\u00e7et disease-related uveitis"],"prefix":"10.1007","volume":"31","author":[{"given":"Kaoru","family":"Takase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Ideguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Uchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,9]]},"reference":[{"key":"1178_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"PP Sfikakis","year":"2001","unstructured":"Sfikakis PP, Theodossiadis PG, Katsiari CG et al (2001) Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et\u2019s disease. Lancet 358:295\u2013296","journal-title":"Lancet"},{"key":"1178_CR2","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","volume":"52","author":"I Tugal-Tutkun","year":"2005","unstructured":"Tugal-Tutkun I, Mudun A, Urgancioglu M et al (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Beh\u00e7et\u2019s disease: an open-label trial. Arthritis Rheum 52:2478\u20132484","journal-title":"Arthritis Rheum"},{"key":"1178_CR3","first-page":"1362","volume":"31","author":"S Ohno","year":"2004","unstructured":"Ohno S, Nakamura S, Hori S et al (2004) Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet\u2019s disease with refractory uveoretinitis. J Rheumatol 31:1362\u20131368","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"1178_CR4","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1136\/ard.61.suppl_2.ii51","volume":"61","author":"PP Sfikakis","year":"2002","unstructured":"Sfikakis PP (2002) Beh\u00e7et\u2019s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):ii51\u2013ii53","journal-title":"Ann Rheum Dis"},{"key":"1178_CR5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E et al (2007) Anti-TNF therapy in the management of Behcet\u2019s disease\u2013review and basis for recommendations. Rheumatology (Oxford) 46:736\u2013741","journal-title":"Rheumatology (Oxford)"},{"key":"1178_CR6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR et al (2002) Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial [comment]. Lancet 359:1541\u20131549","journal-title":"Lancet"},{"key":"1178_CR7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1542-3565(04)00414-8","volume":"2","author":"BE Sands","year":"2004","unstructured":"Sands BE, Blank MA, Patel K et al (2004) Long-term treatment of rectovaginal fistulas in Crohn\u2019s disease: response to infliximab in the ACCENT II study. Clin Gastroenterol Hepatol 2:912\u2013920","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1178_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1572-0241.2005.40647.x","volume":"100","author":"KA Papadakis","year":"2005","unstructured":"Papadakis KA, Shaye OA, Vasiliauskas EA et al (2005) Safety and efficacy of adalimumab (D2E7) in Crohn\u2019s disease patients with an attenuated response to infliximab. Am J Gastroenterol 100:75\u201379","journal-title":"Am J Gastroenterol"},{"key":"1178_CR9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-2036.2008.03902.x","volume":"29","author":"A Oussalah","year":"2009","unstructured":"Oussalah A, Babouri A, Chevaux JB et al (2009) Adalimumab for Crohn\u2019s disease with intolerance or lost response to infliximab: a 3-year single-centre experience. Aliment Pharmacol Ther 29:416\u2013423","journal-title":"Aliment Pharmacol Ther"},{"key":"1178_CR10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.eye.6702352","volume":"21","author":"B Mushtaq","year":"2007","unstructured":"Mushtaq B, Saeed T, Situnayake RD et al (2007) Adalimumab for sight-threatening uveitis in Beh\u00e7et\u2019s disease. Eye 21:824\u2013825","journal-title":"Eye"},{"key":"1178_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","volume":"66","author":"JA Laar van","year":"2007","unstructured":"van Laar JA, Missotten T, van Daele PL et al (2007) Adalimumab: a new modality for Beh\u00e7et\u2019s disease? Ann Rheum Dis 66:565\u2013566","journal-title":"Ann Rheum Dis"},{"key":"1178_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cyto.2005.12.012","volume":"33","author":"S Hale","year":"2006","unstructured":"Hale S, Lightman S (2006) Anti-TNF therapies in the management of acute and chronic uveitis. Cytokine 33:231\u2013237","journal-title":"Cytokine"},{"key":"1178_CR13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","volume":"18","author":"FR Imrie","year":"2007","unstructured":"Imrie FR, Dick AD (2007) Biologics in the treatment of uveitis. Curr Opin Ophthalmol 18:481\u2013486","journal-title":"Curr Opin Ophthalmol"},{"key":"1178_CR14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MAJ.0b013e3180318fbc","volume":"27","author":"PG Theodossiadis","year":"2007","unstructured":"Theodossiadis PG, Markomichelakis NN, Sfikakis PP (2007) Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina 27:399\u2013413","journal-title":"Retina"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1178-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1178-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:18:35Z","timestamp":1559042315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1178-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,9]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1178-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,9]]}}}